The discovery of microbial-sensing proteins called Toll-like receptors is transforming our ... Vaccines for diseases such as AIDS, hepatitis C, malaria, and even cancer might be made more ...

Toll-like receptors (TLRs ... showed promising results for the treatment of viral infections, such as HIV, influenza, HBV and HCV. Efforts to develop TLR antagonists for the treatment of virus ...

Immunotherapy. 2011;3(9):1075-1086. MIP-1β release has also been observed for CD56 neg NK cells from patients with HCV infection. The above results suggest that the aberrant CD56 neg NK subset ...

(Gut) After U.S. guidelines from 2020 recommended broader hepatitis C virus (HCV) testing ... the use of GLP-1 receptor ...

Direct-acting antiviral therapy has reduced the prevalence of hepatitis C viremia over time among adults with HIV infection in the United States. The prevalence of hepatitis C virus (HCV) has ...

Researchers assessed whether participation in Ryan White services improves outcomes among patients with hepatitis C virus and HIV coinfection.

Further, the two samples that they missed were acute-phase sera, and subsequent samples from these same patients proved to be positive for what Chiron now called the hepatitis C virus. Michael ...

That key sits on the surface of human cells. Viruses must bind to cells' receptor proteins to gain entry and start infection. Researchers in Stanford professor Jan Carette's lab uncovered which ...

Hepatitis C is a contagious liver disease caused by the hepatitis C virus, or HCV. In some cases, the virus causes a long lasting infection. When that happens, inflammation from the infection ...

Direct-acting antiviral therapy has reduced the prevalence of hepatitis C viremia over time among adults with HIV infection in the United States. The prevalence of hepatitis C virus (HCV ...